0

Journal Articles

in Thromboembolism/Anticoagulation
 1-20 of 434 Articles
In This Issue of JAMA Internal Medicine |  May 13, 2013
In This Issue of JAMA Internal Medicine
JAMA Intern Med. 2013;173(9):722. doi:10.1001/jamainternmed.2013.51.
Editor's Correspondence |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Intern Med. 2013;173(9):833-834. doi:10.1001/jamainternmed.2013.3763.
Editor's Correspondence |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
JAMA Intern Med. 2013;173(9):833-834. doi:10.1001/jamainternmed.2013.14.
Editor's Correspondence |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?
Joey S. W. Kwong, PhD; Cheuk-Man Yu, MD
JAMA Intern Med. 2013;173(9):835-836. doi:10.1001/jamainternmed.2013.78.
Editor's Correspondence |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?—Reply
András Komócsi, MD, DSc; András Vorobcsuk, MD, PhD; Dániel Aradi, MD, PhD
JAMA Intern Med. 2013;173(9):835-836. doi:10.1001/jamainternmed.2013.424.
Original Investigation |  May 13, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Intern Med. 2013;173(9):743-752. doi:10.1001/jamainternmed.2013.122.
INCLUDES: , Supplemental Content
Original Investigation |  May 06, 2013 ONLINE FIRST
Attending Rounds in the Current Era:  What Is and Is Not Happening
Chad Stickrath, MD; Melissa Noble, BS; Allan Prochazka, MD; et al.
JAMA Intern Med. 2013;():1-6. doi:10.1001/jamainternmed.2013.6041.
In This Issue of JAMA Internal Medicine |  April 08, 2013
In This Issue of JAMA Internal Medicine
JAMA Intern Med. 2013;173(7):486. doi:10.1001/jamainternmed.2013.39.
Research Letters |  April 08, 2013
Patient Information About Warfarin: An Assessment of Accuracy and Readability
Artemis Diamantouros, RPh, MEd; William Bartle, PharmD; William Geerts, MD
JAMA Intern Med. 2013;173(7):582-583. doi:10.1001/jamainternmed.2013.2781.
Invited Commentary |  April 08, 2013
Left Behind:  Ensuring Clarity and Completeness of Our Educational Materials and Messages
Crystal Wiley Cené, MD, MPH; Darren A. DeWalt, MD, MPH
JAMA Intern Med. 2013;173(7):583-584. doi:10.1001/jamainternmed.2013.3779.
Original Investigation |  April 08, 2013
High Variation Between Hospitals in Vena Cava Filter Use for Venous Thromboembolism
Richard H. White, MD; Estella Marie Geraghty, MD, MS, MPH; Ann Brunson, MS; et al.
JAMA Intern Med. 2013;173(7):506-512. doi:10.1001/jamainternmed.2013.2352.
INCLUDES: , Supplemental Content
Viewpoint |  April 08, 2013
The Inferior Vena Cava Filter:  How Could a Medical Device Be So Well Accepted Without Any Evidence of Efficacy?
Vinay Prasad, MD; Jason Rho, MD; Adam Cifu, MD
JAMA Intern Med. 2013;173(7):493-495. doi:10.1001/jamainternmed.2013.2725.
Original Investigation |  April 08, 2013
Indications, Complications, and Management of Inferior Vena Cava Filters:  The Experience in 952 Patients at an Academic Hospital With a Level I Trauma Center
Shayna Sarosiek, MD; Mark Crowther, MD; J. Mark Sloan, MD
JAMA Intern Med. 2013;173(7):513-517. doi:10.1001/jamainternmed.2013.343.
Research Letters |  January 28, 2013
Temporal Trends in Ischemic Stroke and Anticoagulation Therapy Among Medicare Patients With Atrial Fibrillation:  A 15-Year Perspective (1992-2007)
Gautam R. Shroff, MBBS; Craig A. Solid, PhD; Charles A. Herzog, MD
JAMA Intern Med. 2013;173(2):159-160. doi:10.1001/jamainternmed.2013.1579.
Original Investigation |  December 10, 2012
Enoxaparin Outcomes in Patients With Moderate Renal Impairment
Douglas D. DeCarolis, PharmD; Joey G. Thorson, PharmD; Megan A. Clairmont, PharmD; et al.
Arch Intern Med. 2012;172(22):1713-1718. doi:10.1001/2013.jamainternmed.369.
INCLUDES: CME
Invited Commentary |  December 10, 2012
Moderate Renal Impairment and Risk of Bleeding With Anticoagulation:  Comment on “Enoxaparin Outcomes in Patients With Moderate Renal Impairment”
Tracy Minichiello, MD
Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456.
Editor's Correspondence |  November 26, 2012
Administrative Databases and Trends in In-Hospital Deaths in Pulmonary Embolism
Abhishek Deshmukh, MD; Gagan Kumar, MD
Arch Intern Med. 2012;172(21):1694. doi:10.1001/2013.jamainternmed.43.
Invited Commentary |  November 26, 2012
Will Newer Anticoagulants Improve Therapy Persistence?:  Comment on “Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation”
Whitney Maxwell, PharmD, BCPS; Charles L. Bennett, MD, PhD, MPP
Arch Intern Med. 2012;172(21):1689-1690. doi:10.1001/2013.jamainternmed.616.
Research Letters |  November 26, 2012
Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation
Tara Gomes, MHSc; Muhammad M. Mamdani, PharmD, MA, MPH; Anne M. Holbrook, MD, PharmD, MSc, FRCPC; et al.
Arch Intern Med. 2012;172(21):1687-1689. doi:10.1001/archinternmed.2012.4485.
INCLUDES: , Supplemental Content
Invited Commentary |  November 12, 2012
No Place for Novel Oral Anticoagulants in Current Treatment of Acute Coronary Syndromes:  Comment on “Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome”
Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(20):1546-1547. doi:10.1001/2013.jamainternmed.293.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  May 13, 2013
Comparison of Final Infarct Volumes in Patients Who Received Endovascular Therapy or Intravenous Thrombolysis for Acute Intracranial Large-Vessel Occlusions
Srikant Rangaraju, MD; Kumiko Owada, MD; Ali Reza Noorian, MD; et al.
JAMA
Medical News and Perspectives  |  May 01, 2013
Study Ignites Debate on New Anticoagulant
Mike Mitka, MSJ
JAMA
JAMA Patient Page  |  April 17, 2013
Aspirin Therapy
Janet M. Torpy, MD; Edward H. Livingston, MD
JAMA Neurology
Images in Neurology  |  February 25, 2013
Successful Repetitive Intravenous Thrombolysis in a Patient With Recurrent Brainstem Infarctions Due to Megadolichobasilar Ectasia
Melissa Cambron, MD; Robbert-Jan Van Hooff, MD; Koenraad Nieboer, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems